Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 5/25/2026TenNor Surges 177% in Hong Kong Trading Debut
  • 5/25/2026MediLink's B7-H3 ADC Hits Positive Phase 3 Result in Nasopharyngeal Ca...
  • 5/25/2026Innovent Reports Promising ASCO 2026 Data for PD-1/IL-2 Bispecific IBI...
  • 5/25/2026Lepu to Present Updated ASCO 2026 Data for GPC3 ADC in Liver Cancer
  • 5/25/2026Kelun-Biotech RET Inhibitor Lunbotinib Delivers Strong Pivotal NSCLC D...
  • 5/25/2026InnoCare Highlights Promising ASCO 2026 Data for Next-Gen BCL2 Inhibit...
  • 5/25/2026China Issues New Compliance Guidelines for Online Prescription Drug Re...
  • 5/25/2026Yangtze River Pharma Wins China Approval for Homegrown Insomnia Drug F...
  • 5/25/2026Benethera Raises Series A to Advance Treg-Focused Autoimmune Pipeline
  • 5/25/2026China-Developed Cancer Drugs Gain Global Momentum With Fresh ASCO Data...
  • 5/25/2026Boehringer's Zongertinib Wins New China Approval in HER2-Mutant Lung C...
  • 5/22/2026Recent Executive Moves
  • 5/22/2026Bayer Wins China Approval for Kerendia (finerenone) in Heart Failure
  • 5/22/2026Qyuns Therapeutics Expands China Biologics Portfolio With Ustekinumab ...
  • 5/22/2026J&J Wins China Approval for Nipocalimab in Myasthenia Gravis
  • 5/22/2026Nuance Wins China IND Clearance for Actair Allergy Immunotherapy Trial
  • 5/22/2026Pakistan Emerges as New Target for Chinese Pharmaceutical Investment
  • 5/22/2026FDA Warns Chinese API Manufacturer Over Relabeled GLP-1 Ingredients Sh...
  • 5/22/2026Full-Life Raises $150M to Expand Clinical Radiopharma Pipeline and Act...
  • 5/22/2026China Clears First INDs for 25 Novel Drugs Last Week
  • 5/21/2026China to Establish "Whitelist" System to Curb Misuse of Medical Insura...
  • 5/21/2026China Accelerates Stem Cell Race for Parkinson's Disease Therapies
  • 5/21/2026United Labs Wins China IND Clearance for Novel Broad-Spectrum β-Lacta...
  • 5/21/202620n Bio Raises $7.5M Seed+ Round for AI-Driven Macrocyclic Peptide Pla...
  • 5/21/2026Forlong Biotech Raises ~CNY 100M to Advance Cytokine Therapy Pipeline
  • 5/21/2026Neuregen Raises Series A to Advance In-Vivo Cell Reprogramming Pipelin...
  • 5/20/2026China Tightens Standards for Generic Drug CMC and Bioequivalence Studi...
  • 5/20/2026CDE Issues M13A Implementation Guidance and First Low-Risk Formulation...
  • 5/20/2026China Adopts ICH M13A Bioequivalence Guideline for Oral Immediate-Rele...
  • 5/19/2026China Tightens Oversight of Employee BMI Accounts at Retail Pharmacies
  • Page:1/63 Total number of articles:1864: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group